Curexo

KOSDAQ-060280
KOSDAQ
Healthcare Medical - Specialties
Global Rank
#18920
Country Rank
#584
Market Cap
256.01 M
Price
6.23
Change (%)
1.49%
Volume
69,302

Curexo's latest marketcap:

256.01 M

As of 08/13/2025, Curexo's market capitalization has reached $256.01 M. According to our data, Curexo is the 18920th most valuable company globally by market capitalization. Market capitalization, commonly referred to as market cap, represents the total market value of all outstanding shares of a publicly traded company and is often used as a measure of company value.

Market Cap 256.01 M
Revenue (ttm) 20.13 M
Net Income (ttm) -11,671,079.15
Shares Out 41.09 M
EPS (ttm) -0.44
Forward PE 0.00
Ex-Dividend Date n/a
Earnings Date 08/13/2025
Market Cap Chart
Data Updated: 08/13/2025

Curexo's yearly market capitalization.

Curexo has seen its market value grow from ₩130.37 B to ₩354.2 B since 2014, representing a total increase of 171.69% and an annual compound growth rate (CAGR) of 9.87%.
Date Market Cap(₩) Market Cap(USD) Change (%) Global Rank
08/13/2025 ₩354.2 B $256.01 M 33.44% 18920
12/30/2024 ₩265.44 B $177.85 M -65.17% 19717
12/28/2023 ₩762.19 B $586.89 M 191.52% 11938
12/29/2022 ₩261.46 B $206.55 M 5.49% 17846
12/30/2021 ₩247.86 B $208.2 M 18.34% 18604
12/30/2020 ₩209.44 B $192.68 M 32.32% 16964
12/30/2019 ₩158.28 B $136.12 M -26.32% 16570
12/28/2018 ₩214.82 B $191.19 M -24.59% 14146
12/28/2017 ₩284.88 B $264.94 M 107.11% 13401
12/29/2016 ₩137.55 B $112.79 M -15.93% 15383

Company Profile

About Curexo Inc.

Curexo Inc. is a leading developer and seller of medical devices, operating primarily in South Korea and internationally. The company specializes in innovative robotic and implant solutions for medical applications.

Business Divisions

  • Medical Robot Division: Focuses on advanced surgical and rehabilitation robotics.
  • Implant Division: Provides artificial joint prostheses and related solutions.
  • Trading Division: Engages in the import, distribution, and sale of food and food additives.

Key Products

  • CUVIS-joint, ROBODOC, & TSolution One: Artificial joint surgery robots.
  • CUVIS-spine: Navigation-based spine surgery robot.
  • Morning Walk S200: Walking rehabilitation robot system.
  • InMotion Arm: Robotic rehabilitation device for upper limb therapy.

Distribution & Presence

The company supplies its products to hospitals and agencies both domestically and internationally. Founded in 1992, Curexo Inc. is headquartered in Seoul, South Korea.

Frequently Asked Questions

  • What is Curexo's (KOSDAQ-060280) current market cap?
    As of 08/13/2025, Curexo (including the parent company, if applicable) has an estimated market capitalization of $256.01 M USD. This figure represents the total market value of its outstanding shares, including different share classes. Please note that market capitalization fluctuates based on market conditions, and the actual valuation may differ from the latest estimate.
  • Curexo global market capitalization ranking is approximately 18920 as of 08/13/2025. This ranking is relative to all publicly traded companies worldwide and can fluctuate based on market dynamics and the performance of other companies. You can refer to our Global companies market cap ranking for the most up-to-date ranking.

MarketCapWatch.com ranks all listed companies worldwide, providing unique insights into market capitalization across industries. As one of the most comprehensive ranking platforms, it covers companies of all sizes and sectors.

Ranking

Copyright © 2025. All rights reserved

Important Disclaimer: All content provided on this website, including hyperlinked pages, related applications, forums, blogs, social media accounts, and other platforms ("the Site"), is for general informational purposes only and sourced from third-party providers. We make no guarantees regarding the accuracy, completeness, or timeliness of the content.

None of the information presented constitutes financial, legal, or professional advice. Users should conduct their own research, evaluation, and verification before making any decisions. Investing and trading carry significant risks that may lead to substantial losses. Therefore, we strongly recommend consulting a qualified financial advisor before taking any action.